売上総利益、減損損失 - 医薬品、社債利息他2件
- 【期間】
| 年度 | 売上総利益 | 減損損失 - 医薬品 | 社債利息 | 減価償却費 - 建設請負 | 長期借入金 |
|---|
| 2008/03 | 387億 | | - | | 96百万 | | - | | 4.03億 | |
| 2009/03 | 408億 | +5.5% | - | | 47百万 | -51% | - | | 8.41億 | +108.7% |
| 2010/03 | 405億 | -0.9% | - | | - | | - | | 12.9億 | +53.9% |
| 2011/03 | 419億 | +3.6% | - | | - | | - | | 17.7億 | +36.6% |
| 2012/03 | 417億 | -0.4% | - | | - | | - | | 15.5億 | -12.5% |
| 2013/03 | 413億 | -0.9% | - | | - | | - | | 15.3億 | -1.4% |
| 2014/03 | 472億 | +14.2% | - | | - | | - | | 14.1億 | -7.6% |
| 2015/03 | 460億 | -2.5% | - | | - | | - | | 14.6億 | +3.8% |
| 2016/03 | 477億 | +3.6% | - | | - | | - | | 14.9億 | +1.7% |
| 2017/03 | 466億 | -2.3% | 47百万 | | - | | - | | 16.6億 | +11.3% |
| 2018/03 | 481億 | +3.2% | - | | - | | - | | 18.8億 | +13.3% |
| 2019/03 | 456億 | -5.3% | 49百万 | +4.3% | - | | 29百万 | | 19.3億 | +2.9% |
| 2020/03 | 349億 | -23.4% | - | | - | | 29百万 | ±0% | 0.13億 | -99.3% |
| 2021/03 | 327億 | -6.2% | - | | - | | 26百万 | -10.3% | - | |
| 2022/03 | 312億 | -4.5% | - | | - | | 26百万 | ±0% | - | |
| 2023/03 | 324億 | +3.6% | - | | - | | 23百万 | -11.5% | - | |
| 2024/03 | 373億 | +15.3% | - | | - | | - | | - | |
